Imodium (Loperamide Hydrochloride)

Loperamide acts as an agonist at peripheral µ‑opioid receptors in the intestinal wall. By inhibiting acetylcholine release, it slows intestinal motility, increases fluid absorption, and reduces intestinal secretions, which together lessen the number of watery stools.

The exact dose of Imodium is individualized by a healthcare professional based on the severity of symptoms, patient age, weight, and overall health. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety data for loperamide in pregnancy and lactation are limited. It should only be used if the potential benefit outweighs any possible risk, and this decision must be made in consultation with a qualified healthcare provider.

To request Imodium, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both loperamide and diphenoxylate‑atropine reduce intestinal motility, but loperamide acts primarily on peripheral µ‑opioid receptors and does not cross the blood‑brain barrier, resulting in fewer central opioid effects. Diphenoxylate‑atropine contains an anticholinergic component and is classified as a controlled substance in many regions.

Imodium should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct heat, and ensure the container is tightly closed to maintain stability.

Imodium is taken orally, usually with a glass of water. The tablets (or liquid, if available) are swallowed whole; they should not be crushed or chewed. Doses are spaced according to the prescriber’s guidance, and the medication can be taken with or without food.

Serious adverse events, although rare, include paralytic ileus (a severe bowel blockage), cardiac arrhythmias, and severe allergic reactions such as rash, swelling or breathing difficulty. If any of these occur, discontinue the medication and seek immediate medical attention.

Imodium is contraindicated in children younger than two years, in patients with known hypersensitivity to loperamide, and in individuals with active bacterial enterocolitis, pseudomembranous colitis, or severe ulcerative colitis. Caution is also advised for patients with hepatic impairment or a history of constipation.